MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

169.10B

Vuru Grade

54.36/100

Current Price

$61.33
-1.01 (-1.62%)

Growth Price

$54.63
Overvalued by 10.93%

Stability Price

$20.59
Overvalued by 66.43%

Company Metrics

  • P/E 31.32
  • P/S 4.31
  • P/B 3.94
  • EPS 1.96
  • Cash ROIC 12.97%
  • Cash Ratio 0.70
  • Dividend 1.88 / 3.02%
  • Avg. Vol. 11.21M
  • Shares 2.76B
  • Market Cap. 169.10B

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

Revenue Estimates Analysis of: Merck & Co., Inc. (NYSE:MRK)
News Oracle - 6 hours ago
Merck & Co., Inc. (NYSE:MRK) will report its next earnings on 2-Feb-17. The company reported the earnings of $1.07/Share in the last quarter where the estimated EPS by analysts was $0.99/share.
Noteworthy Stocks: Merck & Co., Inc. (NYSE:MRK), Cliffs Natural Resources Inc ... - TRA
Momentum Stocks in Focus: Merck & Co., Inc. (MRK), Cliffs Natural Resources ... - iStreetWire
Merck & Co., Inc. (NYSE:MRK) current consensus investment analysts is to ...
The Independent Republic - 1 hour ago
Merck & Co., Inc. (NYSE:MRK) stock is presently standing at about $62.34 and lots of equity research firms seem to have a target price set on the stock.
Trending Stocks: ArcBest Corporation (NASDAQ:ARCB), Merck & Co., Inc. (NYSE ... - Benchmark Monitor
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
Motley Fool - Jan 6, 2017
Shares of Merck & Co., Inc. (NYSE:MRK), a U.S.-based global drug behemoth, climbed 11% higher in 2016, according to data from S&P Global Market Intelligence, slightly outpacing the 9.5% return of the S&P 500, and putting the SPDR S&P Pharmaceuticals ...
Merck & Company, Inc. (MRK) Raised to "Sell" at Vetr Inc.
The Cerbat Gem - 5 hours ago
Vetr upgraded shares of Merck & Company, Inc. (NYSE:MRK) from a strong sell rating to a sell rating in a research report report published on Thursday morning.
Merck & Company Inc. (new) (MRK) Closes 0.21% Up on the Day for January 16 - Equities.com
Merck & Company, Inc. (MRK) Lifted to "Overweight" at Piper Jaffray Companies - BBNS
Merck & Co., Inc. (MRK) Stock Is Defying the Bears!
Investorplace.com - Jan 4, 2017
The first trading day of 2017 was a mixed session. Although the broader indices ended higher on the day, underneath the surface, things traded in a sloppy fashion.
analysts Recommendations: Merck & Co., Inc. (NYSE:MRK) - News Oracle
Merck & Company Inc. (new) (MRK) Closes 0.03% Down on the Day for January 05 - Equities.com
Merck, IBM Pace DJIA to Wednesday Gain
24/7 Wall St. - Jan 11, 2017
The DJIA stock posting the largest daily percentage gain ahead of the close Wednesday was Merck & Co. Inc. (NYSE: MRK) which traded up about 2.65% at $61.51.
Merck & Co., Inc. (NYSE:MRK) Joins Forces With M2Gen To Explore The ORIEN ...
Market Exclusive - Jan 6, 2017
Merck & Co., Inc. (NYSE:MRK), which is popularly known as MSD outside the United States and Canada, has become part of the Oncology Research Information Exchange Network (ORIEN) Avatar Research Program.
Analysts' Recommendations Trending Stocks: Merck & Co., Inc. (NYSE:MRK ... - Money News
Stock's Stunning Activities: Merck & Co., Inc. (NYSE:MRK)
FactsReporter - Jan 10, 2017
Many analysts have provided their estimated foresights on Merck & Co., Inc. Earnings, with 17 analysts believing the company would generate an Average Estimate of $0.88.
Merck & Company Inc. (new) (MRK) Rises 2.85% for January 11 - Equities.com
Price Target Analysis: Merck & Co., Inc. (NYSE:MRK) - News Oracle
Active Stock Momentum: Merck & Co., Inc. (NYSE:MRK)
FactsReporter - Dec 30, 2016
Many analysts have provided their estimated foresights on Merck & Co., Inc. Earnings, with 17 analysts believing the company would generate an Average Estimate of $0.88.
Merck & Company Inc. (new) (MRK) Closes 0.87% Down on the Day for December 28 - Equities.com
3 Stocks to Watch on Wednesday: Merck & Co., Inc. (MRK), United Continental ...
Investorplace.com - Jan 11, 2017
3 Stocks to Watch on Wednesday: Merck & Co., Inc. (MRK It was a busy afternoon after the bell as two stocks rose late Wednesday in Merck & Co., Inc. (NYSE:MRK) and United Continental Holdings Inc (NYSE:UAL), while one was slumping in Parsley Energy ...
SEC Filings On Watch: United Contl Holdings INC (UAL) Holder Mayo Investment ... - The Herald Beacon